Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 164

    1.

    Getting the iron out: phlebotomy for Alzheimer's disease?

    Dwyer BE, Zacharski LR, Balestra DJ, Lerner AJ, Perry G, Zhu X, Smith MA.

    Med Hypotheses. 2009 May;72(5):504-9. Epub 2009 Feb 4.PMID: 19195795 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Low molecular weight heparins as extended prophylaxis against recurrent thrombosis in cancer patients.

    Engman CA, Zacharski LR.

    J Natl Compr Canc Netw. 2008 Aug;6(7):637-45. Review.PMID: 18691456 [PubMed - indexed for MEDLINE]Related articles

    3.

    Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.

    Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.

    J Natl Cancer Inst. 2008 Jul 16;100(14):996-1002. Epub 2008 Jul 8.PMID: 18612130 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Heparin as an anticancer therapeutic.

    Zacharski LR, Lee AY.

    Expert Opin Investig Drugs. 2008 Jul;17(7):1029-37. Review.PMID: 18549339 [PubMed - indexed for MEDLINE]Related articles

    5.

    Venous thromboembolism prevention in cancer patients: the search for common antecedents.

    Zacharski LR, Engman CA.

    Expert Opin Pharmacother. 2007 Sep;8(13):2117-25. Review.PMID: 17714064 [PubMed - indexed for MEDLINE]Related articles

    6.

    Bloodletting: past and present.

    DePalma RG, Hayes VW, Zacharski LR.

    J Am Coll Surg. 2007 Jul;205(1):132-44. Epub 2007 May 17. No abstract available. PMID: 17617342 [PubMed - indexed for MEDLINE]Related articles

    7.

    Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells.

    Ornstein DL, Zacharski LR.

    Nutr Cancer. 2007;58(1):115-26.PMID: 17571974 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rectus sheath hematoma complicating low-molecular weight heparin therapy.

    Denard PJ, Fetter JC, Zacharski LR.

    Int J Lab Hematol. 2007 Jun;29(3):190-4.PMID: 17474896 [PubMed - indexed for MEDLINE]Related articles

    9.

    Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.

    Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.

    JAMA. 2007 Feb 14;297(6):603-10.PMID: 17299195 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Statins and biomarkers in claudicants with peripheral arterial disease: cross-sectional study.

    DePalma RG, Hayes VW, May PE, Cafferata HT, Mohammadpour HA, Brigg LA, Chow BK, Shamayeva G, Zacharski LR.

    Vascular. 2006 Jul-Aug;14(4):193-200.PMID: 17026909 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.

    Lee DH, Zacharski LR, Jacobs DR Jr.

    Am Heart J. 2006 Jun;151(6):1247.e1-7.PMID: 16781229 [PubMed - indexed for MEDLINE]Related articles

    12.

    Commentary on "The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis".

    Zacharski LR, Engman CA.

    Free Radic Biol Med. 2006 May 15;40(10):1700-1. Epub 2006 Mar 31. Review. No abstract available. PMID: 16678009 [PubMed - indexed for MEDLINE]Related articles

    13.

    Coagulation biology in glioma pathogenesis: a missing link?

    Fadul CE, Zacharski LR.

    J Thromb Haemost. 2005 Sep;3(9):1915-6. No abstract available. PMID: 16102095 [PubMed - indexed for MEDLINE]Related articles

    14.

    The functions of plasminogen activator inhibitor-1: do we have all the pieces of PAI?

    Mulligan-Kehoe MJ, Schwartz GN, Zacharski LR.

    Thromb Res. 2006;117(5):483-6. Epub 2005 Jul 1. No abstract available. PMID: 15993475 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hypercoagulability preceding cancer. The iron hypothesis.

    Zacharski LR.

    J Thromb Haemost. 2005 Mar;3(3):585-8. No abstract available. PMID: 15748256 [PubMed - indexed for MEDLINE]Related articles

    16.

    Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?

    Zacharski LR, Sukhatme VP.

    J Thromb Haemost. 2005 Mar;3(3):424-7. No abstract available. PMID: 15748226 [PubMed - indexed for MEDLINE]Related articles

    17.

    Warfarin versus low-molecular-weight heparin therapy in cancer patients.

    Zacharski LR, Prandoni P, Monreal M.

    Oncologist. 2005 Jan;10(1):72-9. Review.PMID: 15632254 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST).

    Zacharski LR, Chow BK, Howes PS, Lavori PW, Shamayeva G.

    Am Heart J. 2004 Sep;148(3):386-92.PMID: 15389223 [PubMed - indexed for MEDLINE]Related articles

    19.

    Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.

    Zacharski LR, Hommann M, Kaufmann R.

    Expert Rev Cardiovasc Ther. 2004 Sep;2(5):777-84. Review.PMID: 15350179 [PubMed - indexed for MEDLINE]Related articles

    20.

    Thrombosis and Hemostasis Issues in Cancer - Second International Conference. 19-21 September, 2003, Bergamo, Italy.

    Zacharski LR.

    IDrugs. 2003 Nov;6(11):1036-8. No abstract available. PMID: 15270033 [PubMed - indexed for MEDLINE]Related articles

    21.

    Interfering with hemostatic system components: possible new approaches to antiangiogenic therapy.

    Wojtukiewicz MZ, Sierko E, Zacharski LR.

    Semin Thromb Hemost. 2004 Feb;30(1):145-56. Review.PMID: 15034806 [PubMed - indexed for MEDLINE]Related articles

    22.

    Atherosclerosis: a manifestation of chronic iron toxicity?

    Zacharski LR, Gerhard GS.

    Vasc Med. 2003;8(3):153-5. Review. No abstract available. PMID: 14989554 [PubMed - indexed for MEDLINE]Related articles

    23.

    Cancer and venous thromboembolism: a multidisciplinary approach.

    Sørensen HT, Johnsen SP, Nørgård B, Zacharski LR, Baron JA.

    Clin Lab. 2003;49(11-12):615-23. Review.PMID: 14651332 [PubMed - indexed for MEDLINE]Related articles

    24.

    Evaluating the role of serine protease inhibition in the management of tumor micrometastases.

    Putnam JB, Royston D, Chambers AF, Dunbar S, Lemmer JH, Norman P, Travis E, Vaporciyan AA, Yang S, Zacharski LR.

    Oncology (Williston Park). 2003 Oct;17(10 Suppl 10):9-30; quiz 31-2. Review. No abstract available. PMID: 14606367 [PubMed - indexed for MEDLINE]Related articles

    25.

    Heparin treatment of malignancy: the case for clinical trials in colon cancer.

    Zacharski LR.

    Thromb Res. 2003 Jun 1;110(4):213-4. No abstract available. PMID: 14512084 [PubMed - indexed for MEDLINE]Related articles

    26.

    Low-molecular-weight heparin in oncology.

    Zacharski LR, Loynes JT.

    Anticancer Res. 2003 May-Jun;23(3C):2789-93. Review.PMID: 12926114 [PubMed - indexed for MEDLINE]Related articles

    27.

    Occurrence of components of fibrinolytic pathways in situ in laryngeal cancer.

    Wojtukiewicz MZ, Sierko E, Zacharski LR, Rózanska-Kudelska M, Zimnoch L.

    Semin Thromb Hemost. 2003 Jun;29(3):317-20.PMID: 12888936 [PubMed - indexed for MEDLINE]Related articles

    28.

    Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.

    Wojtukiewicz MZ, Sierko E, Zacharski LR, Zimnoch L, Kudryk B, Kisiel W.

    Semin Thromb Hemost. 2003 Jun;29(3):291-300.PMID: 12888933 [PubMed - indexed for MEDLINE]Related articles

    29.

    Malignancy as a solid-phase coagulopathy: implications for the etiology, pathogenesis, and treatment of cancer.

    Zacharski LR.

    Semin Thromb Hemost. 2003 Jun;29(3):239-46. Review.PMID: 12888928 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cytokine signatures in atherosclerotic claudicants.

    DePalma RG, Hayes VW, Cafferata HT, Mohammadpour HA, Chow BK, Zacharski LR, Hall MR.

    J Surg Res. 2003 May 15;111(2):215-21.PMID: 12850465 [PubMed - indexed for MEDLINE]Related articles

    31.

    The coagulation system as a target for experimental therapy of human gliomas.

    Loynes JT, Zacharski LR.

    Expert Opin Ther Targets. 2003 Jun;7(3):399-404. Review.PMID: 12783575 [PubMed - indexed for MEDLINE]Related articles

    32.

    Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial.

    Wojtukiewicz MZ, Kozlowski L, Ostrowska K, Dmitruk A, Zacharski LR.

    Thromb Haemost. 2003 Feb;89(2):405-7. No abstract available. PMID: 12574822 [PubMed - indexed for MEDLINE]Related articles

    33.

    Regression of metastatic non-small cell lung cancer with low molecular weight heparin.

    Loynes JT, Zacharski LR, Rigas JR.

    Thromb Haemost. 2002 Oct;88(4):686. No abstract available. PMID: 12362244 [PubMed - indexed for MEDLINE]Related articles

    34.

    Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy.

    Zacharski LR.

    Cancer Lett. 2002 Dec 1;186(1):1-9. Review.PMID: 12183069 [PubMed - indexed for MEDLINE]Related articles

    35.

    The heparins and cancer.

    Zacharski LR, Loynes JT.

    Curr Opin Pulm Med. 2002 Sep;8(5):379-82. Review.PMID: 12172439 [PubMed - indexed for MEDLINE]Related articles

    36.

    A rebuttal: vitamin K antagonists and cancer survival.

    Zacharski LR, Henderson WG.

    Thromb Haemost. 2002 Jul;88(1):173-4; author reply 175. No abstract available. PMID: 12152670 [PubMed - indexed for MEDLINE]Related articles

    37.

    Role of stored iron in atherosclerosis.

    Howes PS, Zacharski LR, Sullivan J, Chow B.

    J Vasc Nurs. 2000 Dec;18(4):109-14; quiz 115-6. Review.PMID: 11995291 [PubMed - indexed for MEDLINE]Related articles

    38.

    Activity of heparins in experimental models of malignancy: Possible explanations for anticancer effects in humans.

    Ornstein DL, Zacharski LR.

    Clin Hemorheol Microcirc. 2002;26(1):33-40.PMID: 11904469 [PubMed - indexed for MEDLINE]Related articles

    39.

    Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence.

    Cosgrove RH, Zacharski LR, Racine E, Andersen JC.

    Semin Thromb Hemost. 2002 Feb;28(1):79-87. Review.PMID: 11885028 [PubMed - indexed for MEDLINE]Related articles

    40.

    The coagulation system as a target for the treatment of human gliomas.

    Ornstein DL, Meehan KR, Zacharski LR.

    Semin Thromb Hemost. 2002 Feb;28(1):19-28. Review.PMID: 11885022 [PubMed - indexed for MEDLINE]Related articles

    41.

    Treatment of malignancy by activation of the plasminogen system.

    Zacharski LR, Ornstein DL, Gabazza EC, D'Alessandro-Gabazza CN, Brugarolas A, Schneider J.

    Semin Thromb Hemost. 2002 Feb;28(1):5-18. Review.PMID: 11885021 [PubMed - indexed for MEDLINE]Related articles

    42.

    Localization of blood coagulation factors in situ in pancreatic carcinoma.

    Wojtukiewicz MZ, Rucinska M, Zacharski LR, Kozlowski L, Zimnoch L, Piotrowski Z, Kudryk BJ, Kisiel W.

    Thromb Haemost. 2001 Dec;86(6):1416-20.PMID: 11776308 [PubMed - indexed for MEDLINE]Related articles

    43.

    The role of adenosine 5'-diphosphate receptor blockade in patients with cardiovascular disease.

    Solet DJ, Zacharski LR, Plehn JF.

    Am J Med. 2001 Jul;111(1):45-53. Review.PMID: 11448660 [PubMed - indexed for MEDLINE]Related articles

    44.

    Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease.

    Sullivan JL, Zacharski LR.

    Eur J Clin Invest. 2001 May;31(5):375-7. Review. No abstract available. PMID: 11380586 [PubMed - indexed for MEDLINE]Related articles

    45.

    Treatment of cancer with anticoagulants: rationale in the treatment of melanoma.

    Ornstein DL, Zacharski LR.

    Int J Hematol. 2001 Feb;73(2):157-61. Review.PMID: 11372726 [PubMed - indexed for MEDLINE]Related articles

    46.

    Hemostatic effects of tamoxifen in hereditary hemorrhagic telangiectasia.

    Zacharski LR, Dunbar SD, Newsom WA Jr.

    Thromb Haemost. 2001 Feb;85(2):371-2. No abstract available. PMID: 11246565 [PubMed - indexed for MEDLINE]Related articles

    47.

    Venous thromboembolism and cancer.

    Zacharski LR, Ornstein DL.

    N Engl J Med. 2000 Nov 2;343(18):1338. No abstract available. PMID: 11183567 [PubMed - indexed for MEDLINE]Related articles

    48.

    Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin.

    Dunbar SD, Ornstein DL, Zacharski LR.

    Expert Opin Investig Drugs. 2000 Sep;9(9):2085-92. Review.PMID: 11060794 [PubMed - indexed for MEDLINE]Related articles

    49.

    Low-molecular-weight heparin and cancer.

    Zacharski LR, Ornstein DL, Mamourian AC.

    Semin Thromb Hemost. 2000;26 Suppl 1:69-77. Review.PMID: 11011810 [PubMed - indexed for MEDLINE]Related articles

    50.

    Cancer, thrombosis, and anticoagulants.

    Ornstein DL, Zacharski LR.

    Curr Opin Pulm Med. 2000 Jul;6(4):301-8. Review.PMID: 10912637 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...